ASP Isotopes (NASDAQ:ASPI) Stock Price Up 6.8% - What's Next?

Key Points

• Shares of ASP Isotopes rose 6.8% intraday to about $6.06 (high $6.15) on Thursday, with volume ~3.14M shares, roughly 41% below its average daily volume.
• Analysts are mixed: Cantor Fitzgerald started coverage with an "overweight" and $13 target, Canaccord reissued a $11 "buy," Weiss Ratings kept a "sell (d-)," leaving an average rating of Hold and an average target of $13.
• Insiders have been selling recently (COO sold 8,438 shares; CFO sold 80,000), leaving insiders with 14.4% ownership; ASP Isotopes is a development‑stage isotope producer (Molybdenum‑100, Carbon‑14, Silicon‑28) with a market cap around $660M and a negative P/E.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) rose 6.8% on Thursday . The company traded as high as $6.15 and last traded at $6.0640. Approximately 3,138,569 shares changed hands during mid-day trading, a decline of 41% from the average daily volume of 5,340,346 shares. The stock had previously closed at $5.68.

Analysts Set New Price Targets

ASPI has been the topic of several recent research reports. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of ASP Isotopes in a research note on Monday, December 29th. Cantor Fitzgerald initiated coverage on ASP Isotopes in a report on Thursday, December 4th. They issued an "overweight" rating and a $13.00 price target on the stock. Finally, Canaccord Genuity Group reissued a "buy" rating and set a $11.00 price objective on shares of ASP Isotopes in a research note on Monday, November 24th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $13.00.

ASP Isotopes Price Performance

The stock's fifty day moving average price is $6.24 and its 200-day moving average price is $7.62. The company has a debt-to-equity ratio of 1.04, a current ratio of 6.14 and a quick ratio of 6.10. The firm has a market cap of $659.72 million, a price-to-earnings ratio of -4.61 and a beta of 3.55.

Insider Activity at ASP Isotopes

In related news, COO Robert Ainscow sold 8,438 shares of the business's stock in a transaction that occurred on Friday, March 6th. The shares were sold at an average price of $5.44, for a total transaction of $45,902.72. Following the transaction, the chief operating officer directly owned 1,537,817 shares of the company's stock, valued at approximately $8,365,724.48. The trade was a 0.55% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Heather Kiessling sold 80,000 shares of the company's stock in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $5.80, for a total transaction of $464,000.00. Following the completion of the transaction, the chief financial officer owned 732,500 shares in the company, valued at approximately $4,248,500. This represents a 9.85% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 14.40% of the company's stock.

Institutional Investors Weigh In On ASP Isotopes

Several hedge funds have recently modified their holdings of ASPI. Quantbot Technologies LP bought a new position in ASP Isotopes during the third quarter worth $34,000. Ameritas Investment Partners Inc. increased its holdings in shares of ASP Isotopes by 41.2% during the second quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company's stock worth $40,000 after buying an additional 1,600 shares in the last quarter. BNP Paribas Financial Markets raised its stake in shares of ASP Isotopes by 84.9% in the second quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company's stock valued at $41,000 after acquiring an additional 2,548 shares during the last quarter. IFP Advisors Inc acquired a new position in shares of ASP Isotopes in the 4th quarter worth approximately $48,000. Finally, Pictet Asset Management Holding SA acquired a new position in shares of ASP Isotopes in the 4th quarter worth approximately $61,000. 16.80% of the stock is owned by institutional investors.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.